Asia Pacific Intravascular Ultrasound (IVUS) Devices Market

The Asia Pacific intravascular ultrasound devices market is expected to reach US$ 237.06 million by 2028 from US$ 138.26 million in 2021; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028.

The market growth is ascribed to the rising prevalence of coronary disorders and increasing R&D activities along with improving healthcare infrastructure. However, recalls of IVUS restrict the market growth.

Leading market players increase their penetration across emerging markets by expanding their distribution networks and augmented manufacturing capabilities. Emerging markets in South Korea and India are expected to offer potential growth opportunities for the companies offering crucial intravascular ultrasound devices. This can be correlated to the large patient population, high CVD prevalence, increasing disposable incomes, improving healthcare infrastructure, and growing medical tourism in these countries.

Asia Pacific has become a business-friendly and resilient hub due to relatively less stringent regulations and data requirements. As the US and European markets mature, most players are relocating their focus to emerging markets. Increasing investments by market players in emerging countries play a crucial role in the upgrading of technologies in these countries. For instance, in December 2021, Conavi Medical Inc. entered into funding agreements worth US$ 20 million to support the commercialization of its innovative intravascular image guidance technology. Therefore, the rising potential of emerging economies supports the inclination toward CVDs diagnosis.

Various economies worldwide, such as Japan, China, India, and South Korea, are considerably modernizing their healthcare facilities and services. As a result, the life expectancy of people in these countries has increased, leading to the growth in their geriatric population base. Age is a prominent risk factor in the development of CVDs. Heart’s physiological aging, and increased oxidative stress and inflammation are the major factors causing the onset and manifestation of CVDs. Thus, a rise in the elderly population underlines the demand for intravascular ultrasound devices (IVUS).

The interruptions in supply chains and the massive demand for efficient treatments for the treatment of COVID-19 have put the healthcare research industry in Asia Pacific in a crucial position. Prohibited measures have been taken to contain the spread of SARS-CoV-2. Cancer screening, diagnosis, and treatment were either postponed or delayed prioritizing the COVID patients in 2020, which hampered the demand for intravascular ultrasound (IVUS) devices. In addition, inflation, negative GDP, and unemployment struck many countries in the region. The pandemic has affected three main aspects of the global economy: manufacturing, supply chain, and business and financial markets. Medical device manufacturers and suppliers are shifting their focus to developing and supplying COVID-19 essentials and medical devices for respiratory diseases. Patients suffering from hypertension, diabetes, cardiovascular conditions, etc., are more susceptible to the novel coronavirus than individuals who are not suffering from any major health conditions. Researchers are increasingly investing time and resources toward understanding the role of point-of-care ultrasound amid the ongoing pandemic, particularly for dialytic patients. While research and development activities are likely to pick up the pace in the coming years, medical device market players are expected to address issues that hampered supply chains amid stringent trade and transportation restrictions.

Asia Pacific Intravascular Ultrasound (IVUS) Devices Market Revenue and Forecast to 2028 (US$ Mn)

ASIA PACIFIC INTRAVASCULAR ULTRASOUND (IVUS) DEVICES MARKET SEGMENTATION

By Modality

• Virtual Histology IVUS
• iMap IVUS
• Integrated Backscatter IVUS

By Product

• Equipment
• Accessories
  • Catheters
  • Guidewires
  • Others

By End User

• Hospitals and Clinics
• Diagnostic Centers
• Others

By Country

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Company Profiles

• Koninklijke Philips N.V
• GE Healthcare
• Siemens AG
• Boston Scientific Corporation
• Infraredx, Inc.
• Terumo Corporation
• Conavi Medical Inc.
• Canon Medical Systems
• Abbott

Asia Pacific Intravascular Ultrasound (IVUS) Devices Strategic Insights

Strategic insights for the Asia Pacific Intravascular Ultrasound (IVUS) Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Intravascular Ultrasound (IVUS) Devices Report Scope

Asia Pacific Intravascular Ultrasound (IVUS) Devices Regional Insights

The geographic scope of the Asia Pacific Intravascular Ultrasound (IVUS) Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.